The Amanta Healthcare IPO is scheduled to open on September 1, 2025, and will close on September 3, 2025. The basis of allotment is expected on September 4, 2025, while refunds and credit to Demat accounts will be processed on September 5, 2025. The IPO is likely to list on the BSE and NSE on September 8, 2025. This book-built issue aims to raise ₹126 crore entirely through a fresh issue of 1 crore equity shares.
The price band has been set between ₹120 and ₹126 per share, with a lot size of 119 shares, making the minimum retail investment ₹14,994 at the upper price band. For HNIs, the sNII application starts at 14 lots (1,666 shares worth ₹2,09,916), while bNII requires 67 lots (7,973 shares worth ₹10,04,598).
The quota distribution reserves 50% for QIBs, 35% for retail investors, and 15% for NIIs. Financially, the company reported revenues of ₹276.09 crore in 2025 compared to ₹281.61 crore in 2024, with net profit rising sharply to ₹10.50 crore in 2025 from ₹3.63 crore in 2024. Considering the strong profit growth, market experts suggest that the IPO is suitable for long-term investors.
Overview of Contents
About Amanta Healthcare IPO
Amanta Healthcare Limited, established in December 1994, is a well-known pharmaceutical company that focuses on making, developing, and marketing a wide variety of sterile liquid medicines, mainly parenteral products. These products are packed in plastic containers using modern technologies like Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM). The company produces important healthcare solutions such as IV fluids, diluents, eye drops, respiratory care solutions, irrigation fluids, first-aid items, and eye lubricants.
Amanta operates through three main divisions – National Sales, International Sales, and Product Partnerships with Indian and global pharmaceutical companies. Under its own brand, the company offers more than 45 generic products in India through a strong network of 320 distributors and stockists. It also has a growing international presence, exporting to 21 countries across Africa, Latin America, the UK, and other regions, with product registrations in 19 countries.
As of March 31, 2025, Amanta Healthcare employs 1,718 people, working across formulation development, manufacturing, and quality laboratories. Its strengths include being a trusted manufacturer with a wide product range, strong domestic and global marketing networks, large-scale production capabilities, and an experienced management team backed by a skilled workforce.
Amanta Healthcare IPO Overview
| Particulars | Details |
|---|---|
| Issue Type | Book Built Issue |
| Face Value | ₹10 per equity share |
| Price Band | ₹120 – ₹126 per share |
| Lot Size | 119 shares |
| Sale Type | Fresh Issue |
| Total Issue Size | 1,00,00,000 shares (₹126 Cr) |
| Listing At | BSE, NSE |
| Pre-Issue Shareholding | 2,88,29,351 shares |
| Post-Issue Shareholding | 3,88,29,351 shares |
| Retail Investor Quota | Not more than 35% |
| Qualified Institutional Quota | Not more than 50% |
| Non-Institutional Quota | Not more than 15% |
Amanta Healthcare IPO Prospectus
| DRHP | Click here |
| RHP | Click here |
Amanta Healthcare IPO Dates
| Event | Date & Day |
|---|---|
| IPO Opens | September 1, 2025 (Monday) |
| IPO Closes | September 3, 2025 (Wednesday) |
| Basis of Allotment | September 4, 2025 (Thursday) |
| Refund Initiation | September 5, 2025 (Friday) |
| Credit to Demat Accounts | September 5, 2025 (Friday) |
| Listing on Stock Exchange | September 8, 2025 (Monday) |
Amanta Healthcare IPO Lot Size
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 119 | ₹14,994 |
| Retail Maximum | 13 | 1,547 | ₹1,94,922 |
| S-HNI Minimum | 14 | 1,666 | ₹2,09,916 |
| B-HNI Minimum | 67 | 7,973 | ₹10,04,598 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Denis Chem Lab Limited | 5.82 | 15.92 | 9.49% | 61.33 | 176 Cr. |
Object of the Issue
- Capex for civil construction, equipment, plant & machinery for new SteriPort line at Hariyala, Kheda (Gujarat)
- Capex for civil construction, equipment, plant & machinery for new SVP line at Hariyala, Kheda (Gujarat)
- General corporate purposes
Amanta Healthcare IPO Financial Performance
| Particulars | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Total Income | 276.09 | 281.61 | 262.70 |
| Profit After Tax (PAT) | 10.50 | 3.63 | -2.11 |
| EBITDA | 61.05 | 58.76 | 56.31 |
| Net Worth | 96.39 | 66.29 | 62.88 |
| Reserves & Surplus | 67.56 | 39.46 | 36.05 |
| Total Borrowings | 195.00 | 205.23 | 215.66 |
| Assets | 381.76 | 352.12 | 374.06 |
Amanta Healthcare IPO Review
- Sharekhan –
- SMC Global –
- Sushil Finance –
- Canara Bank –
- DRChoksey FinServ –
- Emkay Global –
- Hem Securities –
- IDBI Capital –
- Marwadi Shares –
- Nirmal Bang –
- SBICAP Securities –
- Swastika Investmart –
- Ventura Securities –
- Geojit –
- Reliance Securities –
- Capital Market –
- BP Wealth –
- ICICIdirect –
- Choice Broking
Amanta Healthcare IPO: Key Financials, KPIs, and Investment Outlook
| KPI | Values |
|---|---|
| EBITDA Margin | 22.11% |
| PAT Margin | 3.86% |
| Debt-to-Equity Ratio | 2.02 |
| Earnings Per Share (EPS) | ₹3.71 (Basic) |
| Net Asset Value (NAV) | ₹33.43 |
| Return on Net Worth (RoNW) | 10.89% |
| Return on Equity (ROE) | 12.42% |
| Return on Capital Employed (ROCE) | 13.72% |
| Price/Earning (P/E) Ratio | N/A |
Amanta Healthcare IPO Registrar
MUFG Intime India Pvt Ltd.
Phone: +91-22-4918 6270
Email: amantahealthcare.ipo@linkintime.co.in
Website: https://in.mpms.mufg.com/
IPO Lead Managers aka Merchant Bankers
- Beeline Capital Advisors Pvt Ltd.
Company Address
Amanta Healthcare Ltd.
8th Floor, Shaligram Corporates
C.J. Marg, Ambli,
Ahmedabad, Gujarat, 380058
Phone: 079 67777600
Email: cs@amanta.co.in
Website: https://www.amanta.co.in/
Amanta Healthcare IPO FAQs
What is the issue size of Amanta Healthcare IPO?
The IPO size is approximately ₹126 crore, consisting entirely of a fresh issue of 1 crore equity shares.
What is the price band for Amanta Healthcare IPO?
The price band is fixed at ₹120 to ₹126 per share.
What is the lot size for retail investors in Amanta Healthcare IPO?
The minimum lot size is 119 shares. At the upper price band, the minimum investment is ₹14,994.
When will Amanta Healthcare IPO open and close?
The IPO will open on September 1, 2025 (Monday) and close on September 3, 2025 (Wednesday).
When will the allotment for Amanta Healthcare IPO be finalized?
The allotment is expected on September 4, 2025 (Thursday).
When will Amanta Healthcare IPO list on the stock exchanges?
The shares are scheduled to list on September 8, 2025 (Monday) at BSE and NSE.